Commonwealth Equity Services »

Lineage Cell Therapeutics In shares owned by Commonwealth Equity Services

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Commonwealth Equity Services from 13F filings

Historical chart of Commonwealth Equity Services investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Commonwealth Equity Services

Quarter filed Position value Share count Share price at filing
2024-03-31 $71k 48k 1.49
2023-12-31 $52k 48k 1.09
2023-09-30 $64k 55k 1.17
2023-06-30 $73k 52k 1.42
2023-03-31 $72k 49k 1.48
2022-12-31 $57k 49k 1.16
2022-09-30 $48k 43k 1.12
2022-06-30 $71k 46k 1.56
2022-03-31 $70k 46k 1.54
2021-12-31 $94k 39k 2.43
2021-09-30 $110k 44k 2.50
2021-06-30 $154k 54k 2.83
2021-03-31 $113k 48k 2.34
2020-12-31 $158k 90k 1.76
2020-09-30 $85k 91k 0.93
2020-06-30 $74k 85k 0.87
2020-03-31 $61k 75k 0.82
2019-12-31 $59k 67k 0.88
2019-09-30 $112k 114k 0.98